LENZ Therapeutics
A San Diego-based late-stage clinical company developing innovative ophthalmic pharmaceutical products to improve vision, with a focus on restoring presbyopia-related near vision loss.
HQ location
Solana Beach, United States
Website
Launch date
Employees
Market cap
$849m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
* | $30.0m | Post IPO Equity | |
| Total Funding | 000k | ||
Versant Ventures(exited)
RA Capital Management(exited)
Sectoral Asset Management(exited)
RTW Investments(exited)
Point72(exited)
Alpha Wave Ventures(exited)
Alpha Wave Global(exited)
Samsara BioCapital(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | - | - | 551 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (70 %) | - | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (72 %) | - | - | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 141 % | - | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by LENZ Therapeutics
Edit
ACQUISITION by LENZ Therapeutics Nov 2023